🔎 Trials Near Me

Gara Jalqabaatti › Sukkaraa Gosa 2 › North Carolina › Havelock

Qorannoo klinikaalii Sukkaraa Gosa 2 Havelock, NC keessatti

Qorannoo 13 Sukkaraa Gosa 2 f Havelock fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Namoota walitti qabaa jiraSadarkaa 3
  • Lucas Research, Inc., Morehead City · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Namoota walitti qabaa jiraSadarkaa 3
  • Centricity Research - Morehead City, Morehead City · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07754461

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • West Clinical Research, Morehead City · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • AURORA-2 Clinical Site, Morehead City · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Namoota walitti qabaa jiraSadarkaa 3
  • Centricity Research Morehead City Multispeciality, Morehead City · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Namoota walitti qabaa jiraSadarkaa 2
  • Lucas Research, Inc., Morehead City · Miili 15 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06897475

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Morehead City · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Namoota walitti qabaa jiraSadarkaa 2
  • Lucas Research Inc, Morehead City · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07296484

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Namoota walitti qabaa jiraSadarkaa 3
  • West Clinical Research, Morehead City · Miili 15 fagaatti
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07684144

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

Namoota walitti qabaa jira
  • Centricity Research - Morehead City, Morehead City · Miili 15 fagaatti
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07599982

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Namoota walitti qabaa jiraSadarkaa 2
  • Lucas Research, Inc., Morehead City · Miili 15 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07527650

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Morehead City · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07664553

Qorannoo Sukkaraa Gosa 2 magaalota biroo keessatti

Qorannoo biroo Havelock keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.